IL6 and COVID-19: These findings are consistent with recently reported IL-6 levels in severe COVID-19 patients (~10–40 pg/mL measured in clinical labs) (1–3) and are lower than levels reported in prior ARDS cohorts ( ~100–2000 pg/mL using ELISA) (10–12).